SNEX is now a week further into its post-earnings reset, and the two most interesting signals this week pull in opposite directions: short sellers are still leaving, but the C-suite is selling hard into the weakness.
The short covering that defined last week's note has continued, though the pace has slowed. Short interest has dropped a further 29% over the past week to 7.75% of free float — extending the unwind from the ~11% peak seen ahead of the August earnings print. The raw position has fallen from roughly 5.8 million shares in late July to just over 4 million today. The borrow market remains relaxed throughout this exit: cost to borrow is a negligible 0.48%, and availability — the ratio of shares still available to lend relative to those already borrowed — has actually loosened further to 747%, comfortably above even the loosest reading of the past 52 weeks. Shorts are not being squeezed out; they are walking out through an open door. Options traders are similarly relaxed. The put/call ratio is running at 0.31, fractionally below its 20-day average and essentially flat on the week — no defensive hedging spike, no unusual call accumulation. The positioning read is neutral-to-constructive on the derivative side.
The insider picture, however, tells a more complicated story. The net 90-day insider figure looks large at first glance but almost certainly reflects pre-earnings activity; what stands out in the recent trade log is a wave of selling from senior ranks since the stock broke down. The CFO, William Dunaway, sold 96,490 shares on August 14 for roughly $6.4 million — the largest single transaction in the recent log. The Chief Risk Officer sold over 52,000 shares on August 7, and the CEO, Philip Smith, sold 45,000 shares on July 22 near $74, well above the current $66.40. The Chief Legal Officer, Executive Vice Chairman, and two directors also registered sales in the window. Against this, a single director — Dhamu Thamodaran — bought 2,500 shares on August 10, a $161,000 purchase that is notable only by contrast: one buyer, a dozen sellers.
The Street has turned more cautious in a way that now looks prescient rather than reactive. Jefferies downgraded SNEX to Hold in late July and cut its target to $112 — a move that preceded the earnings collapse and now looks directionally correct, even if the target still sits well above the current price. The mean analyst target of $75 implies modest upside from $66.40, but the recent trajectory of analyst action points toward target cuts rather than upgrades. The ORTEX short score has eased back to 41.8 from a local peak near 47 on August 7, consistent with the unwinding of short positioning rather than any fresh bearish conviction building. Factor scores offer little conviction either way: EPS surprise ranks well at the 84th percentile, but the short score rank sits at just 32 and days-to-cover ranks at 16 — neither screaming crowded nor signalling distress.
Among peers, BGC gained nearly 9% on the week and VIRT added almost 11%, while EVR and PIPR slipped roughly 1-2%. SNEX's 0.65% weekly gain looks pedestrian against the stronger performers in the group, suggesting it has not yet recaptured the sector tailwind that lifted electronic-trading and brokerage names this week.
The next earnings date is November 25, giving the stock over three months to find a new equilibrium. What to watch in the interim is whether insider selling abates — or whether the CFO's $6.4 million exit proves to be the last large transaction, or the beginning of a more sustained distribution pattern.
See the live data behind this article on ORTEX.
Open SNEX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
